William J Garrison1, G Wilson Miller1,2, Kun Qing2, Y Michael Shim3, Jaime F Mata2, Mu He3, Talissa A Altes4, Joanne M Cassani4, Sarah E Struchen2, Roselove N Nunoo-Asare2, Nicholas J Tustison2, Alan M Ropp2, and John P Mugler III1,2
1Biomedical Engineering, University of Virginia, Charlottesville, VA, United States, 2Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, United States, 3Medicine, University of Virginia, Charlottesville, VA, United States, 4Radiology, University of Missouri, Columbia, MO, United States
Synopsis
Same-session repeatability of quantitative measures of gas
uptake derived from MRI of inhaled hyperpolarized 129Xe was assessed
in healthy and COPD subjects, as well as the impact of scan-to-scan lung volume
differences on measured gas uptake. Strong tissue-to-gas and RBC-to-tissue
repeatability was found in same-day dissolved-phase 129Xe MRI scans
performed at one-third of forced vital capacity, and regressing out
scan-to-scan lung volume changes improved repeatability further. COPD subjects
displayed similar or better repeatability when compared with healthy subjects.
Introduction
MRI of inhaled hyperpolarized 129Xe can be used
to derive quantitative measures of gas uptake, and demonstrates high
sensitivity to changes in lung function associated with diseases such as COPD.1-3
Given increasing interest in using this technique to aid clinical
characterization of pulmonary diseases, it is important to characterize measurement
repeatability in order to establish a threshold beyond which between-subject
differences can reasonably be claimed to occur as a result of true
physiological differences, rather than as a result of noise and/or error
inherent in the measurement.
To date, repeatability of RBC-to-gas, tissue-to-gas, and RBC-to-tissue derived from 129Xe
MR imaging has been characterized in healthy subjects and subjects with
COPD scanned on separate days,4,5 and repeatability of spectroscopic
measurements of the RBC-to-tissue ratio has been characterized in healthy
subjects and subjects with IPF scanned in the same session and in separate
sessions.6,7 Here we assess repeatability of RBC-to-gas,
tissue-to-gas, and RBC-to-tissue in healthy subjects and subjects with COPD in
the same session, which should set a lower bound for measurement repeatability
compared to, for example, measurements performed on different days. We further assess
the impact of adjusting gas uptake measures based on scan-to-scan lung volume differences.4,8Methods
For this study, 32 subjects were scanned between March 2014
and December 2015, with four subjects excluded from analysis due to technical failure.
A total of 28 subjects were included in the final analysis, including 17
healthy subjects (age 46-79, %-pred-FEV1 106%±15%,
FEV1/FVC 0.77±0.03) and 11 subjects with COPD (GOLD stages 1-3, age 57-80,
%-pred-FEV1 63%±23%, FEV1/FVC 0.55±0.13). MR studies were performed using a
1.5T scanner (Siemens Avanto), with a flexible 129Xe chest RF coil
(Clinical MR Solutions). Enriched xenon gas (87% 129Xe) was
polarized using a prototype commercial system (XeBox-E10, Xemed). Each subject
received two identical scans at one-third of forced vital capacity (1/3 FVC,
based on spirometry) within a single imaging session. For each scan,
dissolved-phase 129Xe1 and proton acquisitions were
performed in a single breath-hold as previously described.8 Gas-uptake
measures were calculated from each 129Xe acquisition using an IDEAL
fitting algorithm, and within-scan lung volumes were determined by segmenting
proton lung images using a neural network-based toolbox.9 The following measures of repeatability were
applied to whole-lung means: two-way random, single-measure, absolute-agreement
intraclass correlation coefficient (ICC); coefficient of variation (CV); and
coefficient of repeatability (CR). Volume-adjusted repeatability was assessed
by adjusting the second measurement in each subject to account for scan-to-scan
changes in lung volume based on scan-to-scan percentage changes in lung volume
and gas ratio, and calculating ICC, CV, and CR after performing this
adjustment.Results
Fig. 1 depicts the first and second gas uptake measurements
in each individual subject, while Fig. 2 depicts the first and second lung
volume measurements; Figs. 1 and 2 each list corresponding ICC, CV, and CR
results for the healthy and COPD groups. Fig. 3 depicts fits of percent
scan-to-scan changes in gas uptake measures vs. percent changes in lung volume,
produced in the manner shown in Hahn et al.4 Fig. 4 depicts
volume-adjusted repeatability results.Discussion
Repeatability of tissue-to-gas and RBC-to-tissue was greater
than repeatability of RBC-to-gas in these subjects, in general agreement with
previous results.5 It is possible that tissue-to-gas repeatability was
greater than RBC-to-gas repeatability in these subjects as a result of the
higher tissue signal, assuming that the noise amplitudes were similar across
the two measures. RBC-to-tissue repeatability seems to exceed RBC-to-gas
repeatability in part because tissue-to-gas and RBC-to-gas tended to vary
concurrently with one another between scans within a subject, thereby
minimizing RBC-to-tissue variability. Across all three gas uptake measures and
for all three measures of repeatability, subjects with COPD displayed better
repeatability than healthy subjects.
Within-scan lung volume was highly repeatable in the
population studied, as shown in Fig. 2. Accordingly, it seems sensible that
adjusting gas uptake results from the second measurement based on scan-to-scan
changes in lung volume based on the fit shown in Fig. 3 would produce some
benefit to repeatability, but would not erase the bulk of scan-to-scan variation
in gas uptake measures. This is borne out by the results shown in Fig. 4: repeatability
measures improved in the subject sample after adjustment for lung volume, but
noteworthy scan-to-scan variation remained in many subjects even after lung
volume-based correction, indicating significant contribution to variability by
noise or other hitherto-uninvestigated confounds. Relationships between
scan-to-scan changes in gas uptake measures and lung volume in healthy subjects
resembled previous findings.4 COPD subjects generally exhibited
similar behavior to healthy subjects; there was a noteworthy difference in
slope between the two groups, but it is possible that this was a product of the
relatively small number of subjects and/or weak linearity in the COPD data.Conclusion
Strong tissue-to-gas and RBC-to-tissue repeatability was
found in same-day dissolved-phase 129Xe MRI of
healthy subjects and subjects with COPD. Relationships of gas uptake measures
to within-scan lung volume were similar to those previously observed, and
regressing out scan-to-scan lung volume changes produced further improvements
to repeatability, indicating that lung volume changes were an important source
of scan-to-scan gas uptake variation.Acknowledgements
Research reported in this abstract was supported by the National
Heart, Lung, and Blood Institute of the National Institutes of Health under
award number R01 HL109618.References
- Qing K, Mugler JP, Altes TA, et al. Assessment of lung function in asthma and COPD using hyperpolarized 129Xe chemical shift saturation recovery spectroscopy and dissolved-phase MRI. NMR Biomed. 2014;27:1490–1501.
- Qing K, Tustison NJ, Mugler JP, et al. Probing changes in lung physiology in COPD using CT, perfusion MRI, and hyperpolarized xenon-129 MRI. Acad Radiol. 2019;26(3):326–334.
- Myc L, Qing K, He M, et al. Characterisation of gas exchange in COPD with dissolved-phase hyperpolarised xenon-129 MRI. Thorax. 2020;thoraxjnl-2020-214924.
- Hahn AD, Kammerman J, Evans M, et al. Repeatability of regional pulmonary functional metrics of hyperpolarized 129Xe dissolved phase MRI. J Magn Reson Imaging. 2019;50(4):1182–1190.
- Kern AL, Gutberlet M, Qing K, et al. Regional investigation of lung function and microstructure parameters by localized 129Xe chemical shift saturation recovery and dissolved‐phase imaging: a reproducibility study. Magn Reson Med. 2019;81:13–24.
- Kaushik SS, Freeman MS, Yoon SW, et al. Measuring diffusion limitation with a perfusion-limited gas - hyperpolarized 129Xe gas-transfer spectroscopy in patients with idiopathic pulmonary fibrosis. J Appl Physiol (1985). 2014;117(6):577–585.
- Weatherley ND, Stewart NJ, Chan H, et al. Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax. 2019;74(5):500–502.
- Qing K, Tustison NJ, Altes TA, et al. Gas uptake measures on hyperpolarized xenon-129 MRI are inversely proportional to lung inflation level. ISMRM 23rd Annual Meeting and Exhibition. 2015;1488.
- Tustison NJ, Avants BB, Lin Z, et al. Convolutional neural networks with template-based data augmentation for functional lung image quantification. Acad. Radiol. 2019;26(3):412–423.